EPC mobilization after erythropoietin treatment in acute ST-elevation myocardial infarction: the REVEAL EPC substudy

Erythropoietin (EPO) was hypothesized to mitigate reperfusion injury, in part via mobilization of endothelial progenitor cells (EPCs). The REVEAL trial found no reduction in infarct size with a single dose of EPO (60,000 U) in patients with ST-segment elevation myocardial infarction. In a substudy,...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Povsic, Thomas J., Najjar, Samer S., Prather, Kristi, Zhou, Jiying, Adams, Stacie D., Zavodni, Katherine L., Kelly, Francine, Melton, Laura G., Hasselblad, Vic, Heitner, John F., Raman, Subha V., Barsness, Gregory W., Patel, Manesh R., Kim, Raymond J., Lakatta, Edward G., Harrington, Robert A., Rao, Sunil V.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4008147/
https://ncbi.nlm.nih.gov/pubmed/23700090
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11239-013-0944-6
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak